CureVac B.V.(CVAC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CVAC CureVac B.V.

盘后交易 11-22 18:25:13 EST

2.66

+0.10

+3.91%

盘后2.66

+0.000.00%

17:35 EST

最高2.70	最低2.52	成交量47.40万
今开2.59	昨收2.56	日振幅7.03%
总市值5.97亿	流通市值3.29亿	总股本2.24亿
成交额124.74万	换手率0.38%	流通股本1.24亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CVAC","market":"US","secType":"STK","nameCN":"CureVac B.V.","latestPrice":2.66,"timestamp":1732309200000,"preClose":2.56,"halted":0,"volume":474011,"hourTrading":{"tag":"盘后","latestPrice":2.66,"preClose":2.66,"latestTime":"17:35 EST","volume":438,"amount":1169.8873566,"timestamp":1732314933996},"delay":0,"floatShares":123537308,"shares":224314013,"eps":-1.33301,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.1,"latestTime":"11-22 18:25:13 EST","open":2.59,"high":2.7,"low":2.52,"amount":1247420.2881003,"amplitude":0.070313,"askPrice":2.7,"askSize":316,"bidPrice":2.56,"bidSize":42,"shortable":3,"etf":0,"ttmEps":-1.33301,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732323600000},"adr":0,"listingDate":1597377600000,"adjPreClose":2.56,"preHourTrading":{"tag":"盘前","latestPrice":2.54,"preClose":2.56,"latestTime":"09:19 EST","volume":4397,"amount":11427.7379244,"timestamp":1732285152556},"postHourTrading":{"tag":"盘后","latestPrice":2.66,"preClose":2.66,"latestTime":"17:35 EST","volume":438,"amount":1169.8873566,"timestamp":1732314933996},"volumeRatio":0.6706,"impliedVol":0.851,"impliedVolPercentile":0.2063},"requestUrl":"/m/hq/s/CVAC","defaultTab":"news","newsList":[{"id":"2485213293","title":"Curevac N.V.盘中异动 早盘大幅上涨5.08%报2.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485213293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485213293?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:18","pubTimestamp":1732292290,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日00时18分，Curevac N.V.股票出现异动，股价大幅上涨5.08%。截至发稿，该股报2.69美元/股，成交量14.1576万股，换手率0.06%，振幅6.13%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.48%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123001810971a822b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123001810971a822b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4139","CVAC","BK4551"],"gpt_icon":0},{"id":"2485242111","title":"Curevac N.V.盘中异动 快速下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485242111","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485242111?lang=zh_cn&edition=full","pubTime":"2024-11-21 03:40","pubTimestamp":1732131621,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日03时40分，Curevac N.V.股票出现异动，股价快速下挫5.00%。截至发稿，该股报2.38美元/股，成交量59.6109万股，换手率0.27%，振幅6.40%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.26%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112103402298e43ccd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112103402298e43ccd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVAC","BK4551","BK4548","BK4139"],"gpt_icon":0},{"id":"2483851878","title":"Curevac N.V.盘中异动 下午盘股价大跌5.03%报2.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483851878","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483851878?lang=zh_cn&edition=full","pubTime":"2024-11-14 03:29","pubTimestamp":1731526189,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日03时29分，Curevac N.V.股票出现波动，股价急速跳水5.03%。截至发稿，该股报2.74美元/股，成交量49.2466万股，换手率0.22%，振幅5.56%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为0.33%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111403294998e4271a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111403294998e4271a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PULM","BK4007","BK4548","BK4551","CVAC"],"gpt_icon":0},{"id":"2482085429","title":"Curevac N.V.盘中异动 急速上涨5.73%报2.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482085429","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482085429?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:34","pubTimestamp":1731422044,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时34分，Curevac N.V.股票出现异动，股价大幅拉升5.73%。截至发稿，该股报2.95美元/股，成交量10.2448万股，换手率0.05%，振幅6.09%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为0.07%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111222340495be19b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111222340495be19b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4551","BK4548","CVAC"],"gpt_icon":0},{"id":"2481634702","title":"Curevac N.V.盘中异动 下午盘快速拉升5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481634702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481634702?lang=zh_cn&edition=full","pubTime":"2024-11-06 02:54","pubTimestamp":1730832893,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日02时54分，Curevac N.V.股票出现波动，股价快速拉升5.17%。截至发稿，该股报2.85美元/股，成交量16.7937万股，换手率0.07%，振幅6.83%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为1.69%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110602545398e409dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110602545398e409dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4551","BK4548","CVAC"],"gpt_icon":0},{"id":"2479253467","title":"Curevac N.V.盘中异动 下午盘急速上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479253467","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479253467?lang=zh_cn&edition=full","pubTime":"2024-10-30 03:03","pubTimestamp":1730228595,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日03时03分，Curevac N.V.股票出现波动，股价快速拉升5.12%。截至发稿，该股报2.98美元/股，成交量37.6746万股，换手率0.17%，振幅3.18%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为0.25%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103003031598e3f2bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103003031598e3f2bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4551","CVAC","BK4139"],"gpt_icon":0},{"id":"2477327973","title":"Curevac N.V.盘中异动 早盘快速跳水5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477327973","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477327973?lang=zh_cn&edition=full","pubTime":"2024-10-22 21:39","pubTimestamp":1729604355,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日21时39分，Curevac N.V.股票出现异动，股价急速跳水5.02%。截至发稿，该股报2.63美元/股，成交量24.5363万股，换手率0.11%，振幅5.60%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为0.31%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022213916ab6c3e37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022213916ab6c3e37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4551","CVAC","BK4548"],"gpt_icon":0},{"id":"2470729451","title":"Curevac N.V.盘中异动 大幅下跌5.02%报3.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470729451","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470729451?lang=zh_cn&edition=full","pubTime":"2024-09-26 02:35","pubTimestamp":1727289330,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日02时35分，Curevac N.V.股票出现异动，股价快速跳水5.02%。截至发稿，该股报3.03美元/股，成交量29.0049万股，换手率0.13%，振幅5.49%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为0.52%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409260235309719ca8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409260235309719ca8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVAC","BK4139","BK4551","BK4548"],"gpt_icon":0},{"id":"2469124270","title":"Curevac N.V.盘中异动 临近收盘股价大跌5.11%报3.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469124270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469124270?lang=zh_cn&edition=full","pubTime":"2024-09-24 03:39","pubTimestamp":1727120357,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日03时39分，Curevac N.V.股票出现波动，股价快速跳水5.11%。截至发稿，该股报3.07美元/股，成交量32.8859万股，换手率0.15%，振幅4.95%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为2.73%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924033918ab656590&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924033918ab656590&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVAC","BK4551","BK4548","BK4139"],"gpt_icon":0},{"id":"2459202124","title":"Curevac N.V.盘中异动 股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459202124","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459202124?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:31","pubTimestamp":1723728669,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时31分，Curevac N.V.股票出现异动，股价快速上涨5.14%。截至发稿，该股报3.48美元/股，成交量3.0268万股，换手率0.01%，振幅3.78%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.61%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213109a1d47058&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213109a1d47058&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4548","BK4551","CVAC"],"gpt_icon":0},{"id":"2458484915","title":"Curevac N.V.盘中异动 下午盘股价大跌5.06%报3.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458484915","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458484915?lang=zh_cn&edition=full","pubTime":"2024-08-10 03:06","pubTimestamp":1723230363,"startTime":"0","endTime":"0","summary":"北京时间2024年08月10日03时06分，Curevac N.V.股票出现波动，股价急速下挫5.06%。截至发稿，该股报3.29美元/股，成交量25.3645万股，换手率0.11%，振幅7.08%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为2.44%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810030603af96d791&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810030603af96d791&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVAC","BK4548","BK4551"],"gpt_icon":0},{"id":"2457184088","title":"Curevac N.V.盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457184088","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457184088?lang=zh_cn&edition=full","pubTime":"2024-08-07 22:24","pubTimestamp":1723040645,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日22时24分，Curevac N.V.股票出现波动，股价快速上涨5.00%。截至发稿，该股报3.57美元/股，成交量14.1733万股，换手率0.06%，振幅4.26%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为1.81%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807222405af966a63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807222405af966a63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4551","CVAC","BK4548","BK4139"],"gpt_icon":0},{"id":"2457026753","title":"Curevac N.V.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457026753","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457026753?lang=zh_cn&edition=full","pubTime":"2024-08-06 22:08","pubTimestamp":1722953289,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日22时08分，Curevac N.V.股票出现异动，股价大幅拉升5.05%。截至发稿，该股报3.33美元/股，成交量7.7468万股，换手率0.03%，振幅4.08%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为1.41%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806220809941fea3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806220809941fea3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4551","BK4139","CVAC"],"gpt_icon":0},{"id":"2457786027","title":"Curevac N.V.股价重挫10.43% 市值跌7229.09万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457786027","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457786027?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:35","pubTimestamp":1722864950,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时35分，Curevac N.V.股票出现波动，股价急速下挫10.43%。截至发稿，该股报3.09美元/股，成交量14.1664万股，换手率0.06%，振幅5.80%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为1.75%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052135509f10714f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408052135509f10714f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4551","CVAC","BK4548"],"gpt_icon":0},{"id":"2456355932","title":"Curevac N.V.盘中异动 早盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456355932","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456355932?lang=zh_cn&edition=full","pubTime":"2024-08-02 23:01","pubTimestamp":1722610894,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日23时01分，Curevac N.V.股票出现异动，股价急速下跌5.03%。截至发稿，该股报3.40美元/股，成交量56.7188万股，换手率0.25%，振幅4.47%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为1.67%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802230134968234fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802230134968234fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVAC","BK4548","BK4551"],"gpt_icon":0},{"id":"2456430045","title":"Curevac N.V.盘中异动 股价大跌5.31%报3.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456430045","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456430045?lang=zh_cn&edition=full","pubTime":"2024-08-01 23:37","pubTimestamp":1722526640,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日23时37分，Curevac N.V.股票出现波动，股价大幅下跌5.31%。截至发稿，该股报3.57美元/股，成交量14.8559万股，换手率0.07%，振幅3.98%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.92%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801233721aefcb93c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801233721aefcb93c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVAC","BK4139","BK4551","BK4539","IMRX","BK4548","BK4563"],"gpt_icon":0},{"id":"2456165092","title":"Curevac N.V.盘中异动 急速上涨5.26%报3.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456165092","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456165092?lang=zh_cn&edition=full","pubTime":"2024-08-01 02:23","pubTimestamp":1722450210,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日02时23分，Curevac N.V.股票出现波动，股价大幅上涨5.26%。截至发稿，该股报3.80美元/股，成交量59.4197万股，换手率0.26%，振幅8.31%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.77%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801022330aefc7f49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801022330aefc7f49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4551","CVAC","BK4548"],"gpt_icon":0},{"id":"2454871656","title":"Curevac N.V.盘中异动 早盘快速上涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454871656","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454871656?lang=zh_cn&edition=full","pubTime":"2024-07-25 21:38","pubTimestamp":1721914696,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日21时38分，Curevac N.V.股票出现波动，股价大幅拉升5.28%。截至发稿，该股报3.79美元/股，成交量2.6676万股，换手率0.01%，振幅2.50%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.30%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725213816968204f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240725213816968204f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4551","CVAC","BK4139"],"gpt_icon":0},{"id":"2452112487","title":"Curevac N.V.盘中异动 早盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452112487","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452112487?lang=zh_cn&edition=full","pubTime":"2024-07-18 22:02","pubTimestamp":1721311337,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日22时02分，Curevac N.V.股票出现波动，股价快速拉升5.07%。截至发稿，该股报3.84美元/股，成交量16.0302万股，换手率0.07%，振幅5.48%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.14%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718220217aefa57ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718220217aefa57ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVAC","BK4551","BK4139","BK4548"],"gpt_icon":0},{"id":"2452162089","title":"Curevac N.V.盘中异动 快速下挫5.20%报3.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452162089","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452162089?lang=zh_cn&edition=full","pubTime":"2024-07-18 00:42","pubTimestamp":1721234569,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日00时42分，Curevac N.V.股票出现波动，股价大幅下跌5.20%。截至发稿，该股报3.38美元/股，成交量28.8281万股，换手率0.13%，振幅6.88%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为1.91%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718004250941f7f81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718004250941f7f81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4551","CVAC","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.curevac.com","stockEarnings":[{"period":"1week","weight":-0.0412},{"period":"1month","weight":-0.0691},{"period":"3month","weight":-0.2266},{"period":"6month","weight":-0.3062},{"period":"1year","weight":-0.5303},{"period":"ytd","weight":-0.3919}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Curevac N.V.于2020年4月7日根据荷兰法律注册成立。该公司是一家全球性的临床阶段生物制药公司，开发基于信使核糖核酸的新型转化药物，该药物具有改善人们生活的潜力。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.074507},{"month":2,"riseRate":0.25,"avgChangeRate":-0.078931},{"month":3,"riseRate":0.25,"avgChangeRate":-0.042891},{"month":4,"riseRate":0.5,"avgChangeRate":0.009789},{"month":5,"riseRate":0.75,"avgChangeRate":0.226595},{"month":6,"riseRate":0.25,"avgChangeRate":-0.165776},{"month":7,"riseRate":0.25,"avgChangeRate":-0.093754},{"month":8,"riseRate":0.25,"avgChangeRate":-0.027881},{"month":9,"riseRate":0,"avgChangeRate":-0.164639},{"month":10,"riseRate":0.2,"avgChangeRate":-0.117332},{"month":11,"riseRate":0.6,"avgChangeRate":0.261691},{"month":12,"riseRate":0,"avgChangeRate":-0.226567}],"exchange":"NASDAQ","name":"CureVac B.V.","nameEN":"CureVac B.V."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CureVac B.V.(CVAC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CureVac B.V.(CVAC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CureVac B.V.,CVAC,CureVac B.V.股票,CureVac B.V.股票老虎,CureVac B.V.股票老虎国际,CureVac B.V.行情,CureVac B.V.股票行情,CureVac B.V.股价,CureVac B.V.股市,CureVac B.V.股票价格,CureVac B.V.股票交易,CureVac B.V.股票购买,CureVac B.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CureVac B.V.(CVAC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CureVac B.V.(CVAC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}